Sinar Terang Mandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sinar Terang Mandiri Tbk. trades at Rp226 (market cap 906.74B, 724K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Sinar Terang Mandiri Tbk. is far larger — about 5.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sinar Terang Mandiri Tbk. is more actively traded (724K versus 96.7K). Which is the better fit depends on your goals.
| MINE | OBAT | |
|---|---|---|
Market Cap | 906.74B | 167.37B |
Volume | 724K | 96.7K |
Lot | 7.24K | 967 |
Turnover | 160.28M | 23.82M |
Average Price | 221.38 | 246.34 |
Value | 160.28M | 23.82M |
Indicative Equilibrium Price | 226 | 248 |
Indicative Equilibrium Volume | 60 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinar Terang Mandiri Tbk (the Company) was established based on Notarial Deed No. 6 dated 22 December 2004 of Winar Sianet, S.H., Notary in Manado. The parent entity as well as the ultimate parent of the Company is PT Mitra Berkarya Sukses Selalu.
Read more on MINE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →